Clinical Trials Browser

Adenocarcinoma × Ascorbic Acid × 1 year × Clear all

NCT02905578 2025-08-27

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms